Scholarlink

<p>Colorectal cancer (CRC) is a major health concern globally, with lymph node metastasis being a key factor in its spread. The lymph node ratio (LNR), defined as the ratio of pathologically positive lymph nodes to the total number of examined nodes, has been proposed as a prognostic marker in CRC. However, data from prospective cohort studies remain limited. This study aimed to evaluate the association between LNR and overall survival (OS) in patients with colon cancer in a prospective multicentre cohort. A prospective cohort study was conducted across seven Polish surgical centers enrolling 445 patients with primary colon cancer. The study collected survival data until September 30, 2022, focusing on patients aged 18–75 years eligible for radical surgery. Preoperative assessments included demographic information, Body Mass Index (BMI) and histopathological evaluation according to AJCC 8th edition. Surgical complications were graded using the Clavien-Dindo scale. The association between OS and LNR was analysed using a multivariable Cox proportional hazards model adjusting for selected clinical and surgical covariates. In the multivariable Cox model, LNR, BMI, and grade III or higher postoperative complications were independently associated with overall survival. For LNR, a 0.1-unit increase was associated with a 26% increase in the hazard of death (hazard ratio 1.26, 95% CI 1.07–1.48; <i>p</i> = 0.006). In this prospective multicentre cohort, lymph node ratio was associated with overall survival in patients with colon cancer, alongside body mass index and the severity of postoperative complications. These findings suggest that LNR may represent a clinically relevant prognostic marker and warrant further investigation in studies specifically designed to compare its prognostic performance with established nodal staging systems.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Lymph node ratio and overall survival in patients with colon cancer: a prospective multicentre cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月27日

查看全文
  • Marcin Ekman,
  • Elzbieta Jodłowska-Siewert,
  • Marcin Urbanowicz,
  • Maciej Berut,
  • Alan Grabowski,
  • Bartosz Kapturkiewicz,
  • Michał Nycz,
  • Michał Putko,
  • Arkadiusz Szarmach,
  • Wojciech Dudzic,
  • Tomasz Jastrzębski

摘要

Colorectal cancer (CRC) is a major health concern globally, with lymph node metastasis being a key factor in its spread. The lymph node ratio (LNR), defined as the ratio of pathologically positive lymph nodes to the total number of examined nodes, has been proposed as a prognostic marker in CRC. However, data from prospective cohort studies remain limited. This study aimed to evaluate the association between LNR and overall survival (OS) in patients with colon cancer in a prospective multicentre cohort. A prospective cohort study was conducted across seven Polish surgical centers enrolling 445 patients with primary colon cancer. The study collected survival data until September 30, 2022, focusing on patients aged 18–75 years eligible for radical surgery. Preoperative assessments included demographic information, Body Mass Index (BMI) and histopathological evaluation according to AJCC 8th edition. Surgical complications were graded using the Clavien-Dindo scale. The association between OS and LNR was analysed using a multivariable Cox proportional hazards model adjusting for selected clinical and surgical covariates. In the multivariable Cox model, LNR, BMI, and grade III or higher postoperative complications were independently associated with overall survival. For LNR, a 0.1-unit increase was associated with a 26% increase in the hazard of death (hazard ratio 1.26, 95% CI 1.07–1.48; p = 0.006). In this prospective multicentre cohort, lymph node ratio was associated with overall survival in patients with colon cancer, alongside body mass index and the severity of postoperative complications. These findings suggest that LNR may represent a clinically relevant prognostic marker and warrant further investigation in studies specifically designed to compare its prognostic performance with established nodal staging systems.